Hereditary Hemochromatosis Since Discovery of the HFE Gene

• Published in: Clinical chemistry (Baltimore, Md.) Vol. 47; no. 7; pp. 1147 - 1156
• Main Authors: Lyon, Elaine, Frank, Elizabeth L
• Format: Journal Article
• Language: English
• Published: Washington, DC Am Assoc Clin Chem 01.07.2001; American Association for Clinical Chemistry
• Subjects: Biological and medical sciences; Genetic Testing; Hemochromatosis - diagnosis; Hemochromatosis - genetics; Hemochromatosis - metabolism; Hemochromatosis - pathology; Hemochromatosis Protein; Histocompatibility Antigens Class I - genetics; Histocompatibility Antigens Class I - metabolism; HLA Antigens - genetics; HLA Antigens - metabolism; Humans; Investigative techniques, diagnostic techniques (general aspects); Medical sciences; Membrane Proteins; Metabolic diseases; Metals (hemochromatosis...); Mutation; Other metabolic disorders; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Phenotype; Polymerase Chain Reaction; Transferrin - analysis; Human; Membrane protein; Hemochromatosis; Metabolic diseases; Genotype; Iron; Medical screening; Hereditary; Enzymopathy; Genetic determinism; Phenotype; Membrane receptor; Metabolic disorder; Iron ion; Cytogenetics; Diagnosis; Mutation; Molecular biology; Bibliographic review
• ISSN: 0009-9147; 1530-8561
• DOI: 10.1093/clinchem/47.7.1147

Hereditary hemochromatosis is an inherited disorder of iron metabolism that is characterized by excessive iron deposition in major organs of the body. Chronic increased iron absorption leads to multiorgan dysfunction. Since the discovery of the gene responsible for the majority of cases, research has progressed rapidly to identify the gene product, the effects of mutations, and the implications for different populations. The protein product of the HFE gene is a transmembrane glycoprotein, termed HFE, that modulates iron uptake. Mutations in the HFE protein compromise its function and produce disease symptoms. Two mutations, C282Y and H63D, have been linked to the majority of disease cases. We reviewed the recent literature for the molecular basis of hereditary hemochromatosis. Genotypic information was combined with biochemical and clinical phenotypic information to achieve a better understanding of the disease mechanism. This review provides a comprehensive discussion of known mutations in the HFE gene and their phenotypic expression. Diagnostic criteria using molecular genetic techniques in conjunction with traditional biochemical tests are provided. Current methods and limitations of molecular testing are examined in detail. A strategy for population screening and an algorithm for diagnosis that incorporates molecular testing are presented. Treatment by therapeutic phlebotomy and the use of blood obtained from hemochromatosis patients are discussed. Although the disease mechanism has not been completely elucidated, phenotypic and penetrance data are becoming available. Controversy still exists concerning the role of genetic testing in diagnosis and population screening.